Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Actinium Pharmaceuticals Inc ATNM

Healthcare Biotechnology
Actinium Pharmaceuticals, Inc. is a late-stage biopharmaceutical company. The Company is engaged in developing targeted radiotherapies to improve survival for people who have failed existing oncology therapies. The Company’s advanced pipeline candidates include Iomab-B (pre-BLA & MAA (EU)) and Actimab-A. Iomab-B is an induction and conditioning agent prior to bone marrow transplant. Actimab-A... see more

Recent & Breaking News (NYSEAM:ATNM)

Actinium Pharmaceuticals Announces Commencement of Rights Offering Subscription Period

GlobeNewswire February 22, 2018

Actinium Pharmaceuticals Announces Product Showcase and Other Visibility Extending Activities at the BMT Tandem Meetings, the Combined Annual Meetings of the Two Leading Transplant Organizations

GlobeNewswire February 20, 2018

Actinium Appoints Anil Kapur as Chief Commercial Officer to Build Critical Commercial & Launch Capabilities Focused on Myeloablation

GlobeNewswire February 8, 2018

Actinium Pharmaceuticals Reminds Investors of Record Date for Rights Offering

GlobeNewswire February 7, 2018

Actinium Pharmaceuticals Announces Trial to Study Actimab-A in Combination with CLAG-M for Relapsed or Refractory AML Patients

GlobeNewswire February 6, 2018

Actinium Pharmaceuticals to Present at the BIO CEO & Investor Conference

GlobeNewswire February 5, 2018

Biotech Stocks' Research Reports Released on Ampio Pharma, AmpliPhi Biosciences, Actinium Pharma, and BioPharmX

PR Newswire January 25, 2018

Stock Performance Review on Biotech Industry -- Ampio Pharma, AmpliPhi Biosciences, Actinium Pharma, and BioPharmX

PR Newswire October 27, 2017

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Actinium Pharmaceuticals, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

PR Newswire September 5, 2017

Actinium Pharmaceuticals to Participate in the Oppenheimer & Co. Boston Oncology Insights Summit on August 16-17, 2017

GlobeNewswire August 9, 2017

Actinium Announces Closing of Public Offering of Common Stock and Warrants to Purchase Common Stock

GlobeNewswire August 2, 2017

Liolios 6th Annual Gateway Conference to Showcase 100 Companies at the Four Seasons San Francisco on September 6-7

GlobeNewswire August 1, 2017

Mid-Afternoon Market Update: CyberOptics Drops After Q2 Results; Aaron's Shares Surge

Benzinga.com  July 28, 2017

Actinium Announces Pricing of Public Offering of Common Stock and Warrants to Purchase Common Stock

GlobeNewswire July 28, 2017

Actinium Announces Proposed Public Offering of Common Stock and Warrants to Purchase Stock

GlobeNewswire July 27, 2017

Stock Performance Review on Biotech Industry -- BioPharmX, AmpliPhi Biosciences, Actinium Pharma, and Matinas BioPharma

PR Newswire July 25, 2017

Actinium Pharmaceuticals to Host Webinar Focused on Actimab-A and Recent Developments Related to CD33 Targeted AML Therapies on July 13, 2017 at 8:00 am ET

GlobeNewswire July 13, 2017

Actinium Pharmaceuticals to Host Webinar Focused on Actimab-A and Recent Developments Related to CD33 Targeted AML Therapies on July 13, 2017 at 8:00 am ET

GlobeNewswire July 6, 2017

Actinium Pharmaceuticals Issues Mid-Year Letter to Shareholders Highlighting Accomplishments and Significant Value Enumerating Catalysts Over the Coming Quarters

GlobeNewswire June 15, 2017

Actinium Pharmaceuticals Announces Appointment of Nitya Ray, Ph.D. as Executive Vice-President, Head of Product Development, Manufacturing and Supply Chain and Other Key Hires in its Product Development and Manufacturing Teams

GlobeNewswire June 15, 2017